At GenomeMiner, we believe that bioinformatics in combination with DNA sequencing and synthetic DNA will allow us to sustainably produce valuable natural products and even develop new ones. Originally founded as Tupac.Bio, the company started developing software tools for synthetic biology companies. Finding the market demand quite limited, the team started a proof of concept experiment with a local partner to screen for wild microbes with anti-fungal characteristics for downstream analysis. This early-stage work motivated a pivot into genome mining, and focus on obtaining data from organisms in the subtropical region of Okinawa. While the original tenets of the company remain the same, to provide bioinformatics solutions that are intuitive, essential, and collaborative, our vision has expanded to obtain proprietary data to build better genome mining software that is A.I. driven, and be able to develop our own end-products.
Get in touch today and let us know how we can help.
Eli moved to Tokyo for PhD studies in the Department of Computational Biology and Medical Science at the University of Tokyo. His research included analyzing data from high-throughput mutagenic screens, wet-lab work in retinal development, and transcriptome analysis. While enrolled in his PhD he joined a Japanese startup and designed detailed protocols for applying Next-Generation Sequencing to phage display screens and performed business development.
While a PhD student he coauthored a paper with Paul on DNA barcoding. He left his PhD studies to apply himself to Tupac.Bio full-time.
Eli has an MSc in Computer Engineering and is fluent in Mandarin Chinese.
Before joining GenomeMiner, Nick graduated from the Waseda MBA program in 2017. Before that he got his bachelors degree in Economics and Food science (MS) from the University of Wisconsin-Madison and previously worked for one of the biggest pharmaceutical company in Indonesia. He is active in the Tokyo Start up ecosystem and is an angel investor in several companies.
His shared background in life science and finance has given him the ability to translate life science potential into business terms.
Nick is fluent in Indonesian, English and conversational in Japanese.
Justin has a BS in Physics with a minor in CS and originally moved to Japan in 2009 to work as an engineer in the semi-conductor laser industry. He has lead many projects to market both professionally and personally and has over a decade of experience in software and systems development.
He has worked on programs for optical design/simulation, multivariable optimization, and web backend/frontend using C++, Java, and C# languages. He has developed systems for data pipelines, web crawlers, and web backend/frontend using Python, Ruby, and JS/Node.js. Also he has launched apps for iOS using Objective-C and Swift.
Justin is fluent in Japanese.
Dr. Suga is the co-founder of Peptidream (2013 IPO) and professor at University of Tokyo. He is a voluntary advisor.
Dr. Kneller has advanced degrees in multiple areas. He is a professor at University of Tokyo and is involved in vaccine development as well as analysis of the Japanese startup landscape.
Yuki is an angel investor and corporate lawyer working in mergers and acquisitions.